Kawano Yohei

カワノヨウヘイ | Kawano Yohei

Affiliation and department：
Job title： Associate professor/Lecturer

Research field (1)： Clinical pharmacy

Research keywords (4)： Data science , Drug interactions , Drug repositioning , Molecular targeted therapy

Research theme for competitive and other funds (1)：

2015 - 2018 Development of cisplatin / caffeine combined chemotherapy for hepatocellular carcinoma.

Papers (35)：

Yasunari Mano, Kentaro Abe, Mio Takahashi, Tsukasa Higurashi, Yohei Kawano, Satoru Miyazaki, Ayako Maeda-Minami. Optimal Administration of Glycyrrhizin Avoids Pharmacokinetic Interactions With High-dose Methotrexate and Exerts a Hepatoprotective Effect. Anticancer research. 2023. 43. 4. 1493-1501
Bingyang Xue, Yasuyoshi Ishiwata, Yohei Kawano, Hiromitsu Takahashi, Kenichi Negishi, Takao Aoyama, Masashi Nagata. Paliperidone-Induced Acute Hyperglycemia Is Caused by Adrenaline Secretion via the Activation of Hypothalamic AMP-Activated Protein Kinase. Biological & pharmaceutical bulletin. 2022. 45. 11. 1669-1677
Ayako Maeda-Minami, Maiko Hosokawa, Yumi Ishikura, Atsuto Onoda, Yohei Kawano, Kenichi Negishi, Shuji Shimada, Tomomi Ihara, Masao Sugamata, Ken Takeda, et al. Relationship Between Leukotriene Receptor Antagonists on Cancer Development in Patients With Bronchial Asthma: A Retrospective Analysis. Anticancer research. 2022. 42. 7. 3717-3724
田中怜, 飯島久子, 青山隆夫, 石川寛, 佐藤淳也, 川岸佐和子, 河野洋平, 梅坪翔太, 佐藤哲, 篠道弘. 医療用麻薬に関連するインシデント/アクシデントの調査と経験年数に着目した相関解析. 日本緩和医療薬学雑誌. 2022. 15. 1. 13-20
Yohei Kawano, Maki Obana, Masashi Nagata, Yasunari Mano, Maho Katsuyama, Yuichiro Yamamoto, Ayako Maeda-Minami, Kenichi Negishi, Masamichi Takagi, Shuji Shimada, et al. The antiplatelet effect of mirtazapine is mediated by co-blocking 5-HT2A and α2-adrenergic receptors on platelets: An in vitro human plasma-based study. European journal of pharmacology. 2022. 917. 174640-174640

ｍore...

MISC (54)：

水野麻衣子, 河野洋平, 青山隆夫. 尋常性ざ瘡治療に用いられるスピロノラクトン及びその代謝物であるカンレノンが表皮角化細胞の角化に及ぼす影響の検討. 日本薬学会年会要旨集. 2022. 142年会. 27PO1-41S
中村朋瑛, 上原佳奈枝, 河野洋平, 青山隆夫. カフェインによるシスプラチン誘発性細胞死の作用増強メカニズムの解明肝細胞がん細胞株を用いた検討. 日本薬学会年会要旨集. 2022. 142年会. 27PO1-74S
橋本佳奈, 河野洋平, 永田将司, 青山隆夫. ラットにおけるカフェインとその代謝物の体内動態の検討. 日本薬学会年会要旨集. 2022. 142年会. 27PO4-04S
後藤奈津子, 河野洋平, 前田絢子, 鈴木立紀, 真野泰成, 青山隆夫. 経口抗凝固薬の抗凝固効果に影響を与える併用薬の網羅的探索研究. 日本薬学会年会要旨集. 2022. 142年会. 28PO1-28S
小池翼, 近藤翔太, 河野洋平, 青山隆夫. 高分子ポリマーのコーティングよる薬物非吸着性輸液ラインの開発インスリンの吸着からの検討. 日本薬学会年会要旨集. 2022. 142年会. 28PO1-35S

ｍore...

Education (3)：

2008 - 2012 University of Miyazaki Graduate School Doctoral course at Graduate school of medicine
2006 - 2008 University of Miyazaki Graduate School Master's Program, Graduate School of Medicine
2001 - 2005 Tokyo university of pharmacy Faculty of Pharmacy Department of Pharmacy

Professional career (1)：

博士(医学) (宮崎大学)

Work history (5)：

2022/04 - 現在 Tokyo University of Science Faculty of Pharmaceutical Sciences Department of Pharmacy Associate professor/Lecturer
2021/04 - 2022/03 Tokyo University of Science Faculty of Pharmaceutical Sciences Department of Pharmacy
2016/04 - 2021/03 Tokyo university of science Faculty of Pharmaceutical Sciences Department of Pharmacy Assistant Professor
2012/04 - 2016/03 University of miyazaki hospital Department of pharmacy Pharmacist
2005/04 - 2008/03 University of miyazaki hospital Department of pharmacy Pharmacist

Committee career (3)：

2023/04 - 2024/03 Japanese Society of Pharmaceutical Health Care and Science Delegate
2019/03 - 2019/03 日本薬学会第139年会組織委員
2018/03 - 2018/06 日本薬学会医療薬科学部会医療薬学フォーラム2018・第26回クリニカルファーマシーシンポジウム運営委員

Awards (9)：

2022/04 - 日本薬学会日本薬学会第142年会学生優秀発表賞カフェインによるシスプラチン誘発性細胞死の作用増強メカニズムの解明-肝細胞がん細胞株を用いた検討-
2022/04 - 日本薬学会日本薬学会第142年会学生優秀発表賞高分子ポリマーのコーティングよる薬物非吸着性輸液ラインの開発-インスリンの吸着からの検討-
2021/08 - Japanese Society of Pharmaceutical Health Care and Sciences JPHCS Paper Award Prediction of the permeability of antineoplastic agents through nitrile medical gloves by zone classification based on their physicochemical properties
2021/07 - Japanese Society of Drug Safety JASDS Best Poster Award
2019/06 - Japanese society of pharmaceutical palliative care and science Excellent Presentation Award Development of cisplatin and caffeine combination chemotherapy for triple negative breast cancer ~ Basic study on efficacy and safety using cultured cells and mouse model ~

Show all

Association Membership(s) (6)：

Japanese Society for Pharmaceutical Palliative Care and Sciences , Japanese Society of Drug Informatics , The Pharmaceutical Society of Japan , Japanese Society of Pharmaceutical Health Care and Sciences , Japanese Cancer Association , The Japanese Association for Molecular Target Therapy of Cancer

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page